| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1017/S0954579406060585 |
| P698 | PubMed publication ID | 17064435 |
| P2093 | author name string | Michael E Thase | |
| P2860 | cites work | Lifetime Prevalence and Age-of-Onset Distributions of DSM-IV Disorders in the National Comorbidity Survey Replication | Q22253034 |
| Meta-analysis of the reversible inhibitors of monoamine oxidase type A moclobemide and brofaromine for the treatment of depression | Q28138066 | ||
| Impact of antidepressant discontinuation after acute bipolar depression remission on rates of depressive relapse at 1-year follow-up | Q28182929 | ||
| Moclobemide vs. imipramine in bipolar depression: a multicentre double-blind clinical trial | Q28208895 | ||
| Two-year outcomes for interpersonal and social rhythm therapy in individuals with bipolar I disorder | Q28270795 | ||
| Comorbidity of Mood and Anxiety Disorders: The Rule, Not the Exception? | Q29029654 | ||
| A Double-Blind, Placebo-Controlled, Prophylaxis Study of Lamotrigine in Rapid-Cycling Bipolar Disorder | Q29394100 | ||
| Lamotrigine treatment of bipolar disorder: data from the first 500 patients in STEP-BD. | Q30910329 | ||
| Long-term implications of early onset in bipolar disorder: data from the first 1000 participants in the systematic treatment enhancement program for bipolar disorder (STEP-BD). | Q30925648 | ||
| Clinical and diagnostic implications of lifetime attention-deficit/hyperactivity disorder comorbidity in adults with bipolar disorder: data from the first 1000 STEP-BD participants | Q30991875 | ||
| Remission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors | Q32069179 | ||
| A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. Lamictal 602 Study Group. | Q33844681 | ||
| Development and validation of a screening instrument for bipolar spectrum disorder: the Mood Disorder Questionnaire | Q33923768 | ||
| A placebo-controlled study of lamotrigine and gabapentin monotherapy in refractory mood disorders | Q33927263 | ||
| Double-blind, placebo-controlled comparison of imipramine and paroxetine in the treatment of bipolar depression | Q33949128 | ||
| The prevalence and disability of bipolar spectrum disorders in the US population: re-analysis of the ECA database taking into account subthreshold cases | Q33963449 | ||
| Long-term lithium therapy for bipolar disorder: systematic review and meta-analysis of randomized controlled trials | Q33975437 | ||
| Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review | Q33988376 | ||
| Randomized trial of a population-based care program for people with bipolar disorder | Q44927545 | ||
| Tranylcypromine versus imipramine in anergic bipolar depression | Q45000348 | ||
| Cardiovascular profile of duloxetine, a dual reuptake inhibitor of serotonin and norepinephrine | Q45288094 | ||
| A prospective investigation of the natural history of the long-term weekly symptomatic status of bipolar II disorder. | Q45931601 | ||
| Agitated "unipolar" depression re-conceptualized as a depressive mixed state: implications for the antidepressant-suicide controversy | Q46096383 | ||
| The long-term natural history of the weekly symptomatic status of bipolar I disorder | Q46317822 | ||
| Divalproex in the treatment of bipolar depression: a placebo-controlled study | Q46394405 | ||
| Atypical depression: a variant of bipolar II or a bridge between unipolar and bipolar II? | Q46500261 | ||
| A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression | Q46580881 | ||
| Bupropion SR for the treatment of substance-abusing outpatient adolescents with attention-deficit/hyperactivity disorder and mood disorders | Q46785465 | ||
| Treatment-resistant bipolar depression: a STEP-BD equipoise randomized effectiveness trial of antidepressant augmentation with lamotrigine, inositol, or risperidone | Q46921502 | ||
| Risk of switch in mood polarity to hypomania or mania in patients with bipolar depression during acute and continuation trials of venlafaxine, sertraline, and bupropion as adjuncts to mood stabilizers | Q46921505 | ||
| Diagnosing bipolar disorder and the effect of antidepressants: a naturalistic study. | Q51972199 | ||
| Early symptoms of mania and the role of parental risk. | Q52997457 | ||
| Evidence-Based Health Policy---Lessons from the Global Burden of Disease Study | Q53681960 | ||
| Perceptions and Impact of Bipolar Disorder | Q54075514 | ||
| Clinical Factors in Lithium Carbonate Prophylaxis Failure | Q54507329 | ||
| Switching From 'Unipolar' to Bipolar II | Q60447092 | ||
| Efficacy of moclobemide in different patient groups: a meta-analysis of studies | Q67514600 | ||
| MAOIs in adolescent major depression unresponsive to tricyclic antidepressants | Q67980751 | ||
| Is bipolar II a unique disorder? | Q68390412 | ||
| Induction of mania with selective serotonin re-uptake inhibitors and tricyclic antidepressants | Q72078495 | ||
| Wartime changes in hospital admissions for schizophrenia. A comparison of admission for schizophrenia and other psychoses in six countries during World War II | Q72903431 | ||
| Venlafaxine monotherapy in women with bipolar II and unipolar major depression | Q73897688 | ||
| A randomized study of family-focused psychoeducation and pharmacotherapy in the outpatient management of bipolar disorder | Q73918315 | ||
| Induction of mania and cycle acceleration in bipolar disorder: effect of different classes of antidepressant | Q74283261 | ||
| Bipolar disorder--a seriously underestimated health burden | Q80094284 | ||
| Stabilization in the treatment of mania, depression and mixed states | Q87454629 | ||
| Bipolar depression: pharmacotherapy and related therapeutic strategies | Q34052825 | ||
| Bipolar disorder therapeutics: maintenance treatment | Q34052830 | ||
| Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression | Q34275783 | ||
| Antidepressants for bipolar depression: a systematic review of randomized, controlled trials | Q34344394 | ||
| Comparing diagnostic checklists for pediatric bipolar disorder in academic and community mental health settings | Q34482994 | ||
| A randomized controlled study of cognitive therapy for relapse prevention for bipolar affective disorder: outcome of the first year | Q34531152 | ||
| A double-blind, placebo-controlled trial of the safety and efficacy of selegiline transdermal system without dietary restrictions in patients with major depressive disorder. | Q34532080 | ||
| Efficacy and tolerability of venlafaxine compared with selective serotonin reuptake inhibitors and other antidepressants: a meta-analysis | Q34620226 | ||
| Report of the Texas Consensus Conference Panel on medication treatment of bipolar disorder 2000. | Q34633988 | ||
| Rash in multicenter trials of lamotrigine in mood disorders: clinical relevance and management. | Q35005642 | ||
| Suicidal behaviour in bipolar disorder: risk and prevention | Q35129379 | ||
| Treatment of bipolar depression: current status, continued challenges, and the STEP-BD approach | Q35142091 | ||
| 'Atypical' antidepressants in overdose: clinical considerations with respect to safety | Q35162333 | ||
| A putative relationship between valproic acid and polycystic ovarian syndrome: implications for treatment of women with seizure and bipolar disorders | Q35179904 | ||
| Antidepressant monotherapy for bipolar type II major depression | Q35592485 | ||
| Safety and tolerability of lamotrigine for bipolar disorder | Q35645906 | ||
| Adverse metabolic effects associated with atypical antipsychotics: literature review and clinical implications | Q35693269 | ||
| A perspective on the use of psychoeducation, cognitive-behavioral therapy and interpersonal therapy for bipolar patients | Q35947317 | ||
| Searching for behavioral indicators of bipolar II in patients presenting with major depressive episodes: the "red sign," the "rule of three" and other biographic signs of temperamental extravagance, activation and hypomania | Q36039804 | ||
| Bipolar depression: issues in diagnosis and treatment | Q36297923 | ||
| Selective serotonin reuptake inhibitors in pediatric depression: is the balance between benefits and risks favorable? | Q36428426 | ||
| Developmental Pathways to Bipolarity: Are Juvenile-Onset Depressions Pre-Bipolar? | Q40442922 | ||
| MAOIs in the contemporary treatment of depression | Q40444762 | ||
| Family-focused treatment of bipolar disorder: 1-year effects of a psychoeducational program in conjunction with pharmacotherapy | Q40744586 | ||
| Antidepressant-associated mania: a controlled comparison with spontaneous mania | Q42282186 | ||
| A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder. | Q42613693 | ||
| A pooled analysis of 2 placebo-controlled 18-month trials of lamotrigine and lithium maintenance in bipolar I disorder. | Q42625302 | ||
| Pattern of response to divalproex, lithium, or placebo in four naturalistic subtypes of mania | Q43942949 | ||
| Trends in use of antidepressants, lithium, and anticonvulsants in Kaiser Permanente-insured youths, 1994-2003. | Q43948591 | ||
| Trends in the treatment of bipolar disorder by outpatient psychiatrists | Q44013090 | ||
| A randomized trial comparing paroxetine and venlafaxine in the treatment of bipolar depressed patients taking mood stabilizers. | Q44044001 | ||
| Topiramate versus bupropion SR when added to mood stabilizer therapy for the depressive phase of bipolar disorder: a preliminary single-blind study | Q44103185 | ||
| A double-blind, randomized, placebo-controlled study of quetiapine as adjunctive treatment for adolescent mania | Q44168457 | ||
| Valproate is associated with new-onset oligoamenorrhea with hyperandrogenism in women with bipolar disorder | Q44178364 | ||
| Validating antidepressant-associated hypomania (bipolar III): a systematic comparison with spontaneous hypomania (bipolar II). | Q44266751 | ||
| Screening for bipolar disorder in the community | Q44318544 | ||
| A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder | Q44403599 | ||
| Maintenance efficacy of divalproex in the prevention of bipolar depression | Q44464135 | ||
| Treatment of imipramine-resistant recurrent depression, IV: A double- blind crossover study of tranylcypromine for anergic bipolar depression | Q44555889 | ||
| Suicide risk in bipolar disorder during treatment with lithium and divalproex | Q44586528 | ||
| Antidepressant-related deaths and antidepressant prescriptions in England and Wales, 1998-2000. | Q44710932 | ||
| Short-term fluoxetine monotherapy for bipolar type II or bipolar NOS major depression - low manic switch rate | Q44783521 | ||
| P433 | issue | 4 | |
| P921 | main subject | bipolar depression | Q56014658 |
| P304 | page(s) | 1213-1230 | |
| P577 | publication date | 2006-01-01 | |
| P1433 | published in | Development and Psychopathology | Q5266724 |
| P1476 | title | Bipolar depression: diagnostic and treatment considerations | |
| P478 | volume | 18 |
| Q36562178 | A bibliometric analysis of bipolar affective disorders using density-equalizing mapping and output benchmarking. |
| Q36866555 | Adjunctive Behavioral Activation for the Treatment of Bipolar Depression: A Proof of Concept Trial |
| Q35237072 | Challenges in the diagnosis and treatment of pediatric bipolar depression. |
| Q47857341 | Characteristics of depression among offspring at high and low familial risk of bipolar disorder. |
| Q64078592 | Comments on "Stressful Life Events and Relapse in Bipolar Affective Disorder" |
| Q40659437 | Current prescription pattern of maintenance treatments for bipolar patients in Korea: A focus on the transition from acute treatments |
| Q33588628 | Dysregulation of leukocyte gene expression in women with medication-refractory depression versus healthy non-depressed controls |
| Q33553208 | Effectiveness and safety of the combination of fluoxetine and olanzapine in outpatients with bipolar depression: an open-label, randomized, flexible-dose study in Puerto Rico |
| Q48684627 | Influence of family history of major depression, bipolar disorder, and suicide on clinical features in patients with major depression and bipolar disorder |
| Q37423311 | Positron emission tomography quantification of serotonin-1A receptor binding in medication-free bipolar depression |
| Q48895126 | Staying at the crossroads: assessment of the potential of serum lithium monitoring in predicting an ideal lithium dose |
| Q40558739 | The Risk of Treatment-Emergent Mania With Methylphenidate in Bipolar Disorder |
| Q48135219 | Trends in the psychopharmacological treatment of bipolar disorder: a nationwide register-based study. |
| Q48889139 | Was it something I did wrong? A qualitative analysis of parental perspectives of their child's bipolar disorder |
Search more.